Class II-Associated Invariant Chain Peptide Expression on Myeloid Leukemic Blasts Predicts Poor Clinical OutcomeMartine E.D. Chamuleau, Gert J. Ossenkoppele, Theresia M. Westers et al.|Cancer Research|2004Cited by 63
The IARC Perspective on Cervical Cancer ScreeningVéronique Bouvard, Béatrice Lauby-Secretan, Nicolas Wentzensen et al.|Obstetrical & Gynecological Survey|2022Cited by 10